Trial Information
Diagnosis of Sceletal Metastases in c. Mammae: 18F-NaF-PET/Lowdose-CT Versus 99mTc HDP Bone Scintigraphy
Inclusion Criteria:
- histologically proven c. mammae
- clinically suspicion of bone metastases
Exclusion Criteria:
- age under 18 years
- diabetes mellitus
- pregnancy
- other known malignant disease
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Principal Investigator
Christine Winkler, Dr.
Investigator Role:
Principal Investigator
Investigator Affiliation:
Dep. of Nuclear Medicine & PET, Rigshospitalet, Denmark
Authority:
Denmark: The Danish National Committee on Biomedical Research Ethics
Study ID:
H-3-2010-019
NCT ID:
NCT01224873
Start Date:
October 2010
Completion Date:
September 2013
Related Keywords:
- Breast Cancer
- breast cancer
- bone metastasis
- comparison of diagnostic methods
- bone scintigraphy
- fluoride PET/CT
- FDG-PET/CT
- Breast Neoplasms
- Neoplasm Metastasis